# American Red Cross Blood Services – FDA Inspection, Jun 8, 2023

Source: https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services/ce11abdb-dd30-4eed-98ff-e0103725c04e
Source feed: FDA_Inspections

> FDA inspection 1208160 of American Red Cross Blood Services, June 08, 2023. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208160
- Company Name: American Red Cross Blood Services
- Inspection Date: 2023-06-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1263330 - 2025-03-05
- FDA Inspection 1087334 - 2019-03-27
- FDA Inspection 1012871 - 2017-05-17
- FDA Inspection 929534 - 2015-06-09
- FDA Inspection 852329 - 2013-10-24

## Related Officers

- [Company Rep](https://www.keypedia.com/people/leslie-w-gilbert/5c8b9e87-9563-4403-89ad-cfa3282a1ba5)

Company: https://www.keypedia.com/companies/american-red-cross-blood-services/897bd61b-e42b-4be0-a709-7cc23cb680e1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d